GlassScriptPhysician profile
Loc T Vu
NPI 1508836321
$2,299.68
in general payments reported to CMS, 2019-2025
20 companies · $567 in 2025
The $567 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.05 · 2020: $93.23 · 2021: $99.28 · 2022: $372 · 2023: $507 · 2024: $642 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $672.11 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $373.82 | 2024-2025 | Jardiance |
| Sumitomo Pharma America, INC. | $178.64 | 2023-2025 | Gemtesa |
| Pfizer INC. | $167.89 | 2020-2024 | |
| Amgen INC. | $140.58 | 2021-2023 | Repatha |
| Si-Bone, INC. | $138.21 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $124.72 | 2023 | Dupixent |
| Gilead Sciences, INC. | $116.15 | 2024 | |
| Lilly USA, LLC | $77.55 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Phathom Pharmaceuticals, INC. | $58.50 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $58.45 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $37.48 | 2020 | |
| Glaxosmithkline, LLC. | $33.08 | 2022-2023 | Shingrix |
| Otsuka America Pharmaceutical, INC. | $25.97 | 2025 | Rexulti |
| Astellas Pharma US INC | $17.96 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.63 | 2025 | |
| Novo Nordisk INC | $17.45 | 2024 | Ozempic, Rybelsus |
| Abbott Laboratories | $15.61 | 2021 | |
| Abbvie INC. | $14.67 | 2022 | |
| Exact Sciences Corporation | $13.21 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loc Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.